Mercedes Tariff Response, Novo Nordisk Competitors, Greencore Deal

On this episode of Stock Movers:
- Mercedes-Benz Group AG is considering withdrawing its least expensive cars from the US because President Donald Trump’s auto tariffs would likely make their sales economically unfeasible, according to people familiar with the matter.
- European pharma stocks could be in focus on Wednesday after a selloff in US peers following the close of European trading on Tuesday. Meanwhile, also watch Novo Nordisk and obesity drug peers after US firm Hims & Hers Health said it was broadening its weight-loss offerings.
- Irish convenience food manufacturer Greencore Group Plc agreed to buy Bakkavor Group Plc in a deal that values its London-listed rival at about £1.2 billion. The company will pay 85 pence in cash and 0.604 Greencore shares for each Bakkavor share, according to a statement, which said the Bakkavor board is inclined to recommend the in-principle agreement to shareholders.

See omnystudio.com/listener for privacy information.